Changes in surrogate outcomes can be translated into clinical outcomes using a Monte Carlo model
Author:
Publisher
Elsevier BV
Subject
Epidemiology
Reference65 articles.
1. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies;Lesko;Annu Rev Pharmacol Toxicol,2001
2. Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop;De Gruttola;Control Clin Trials,2001
3. A regulatory authority's opinion about surrogate endpoints;Temple,1995
4. Surrogate endpoints: a basis for a rational approach;Boissel;Eur J Clin Pharmacol,1992
5. Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshop;Albert;Stat Med,1998
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug–drug interactions with warfarin: A systematic review and meta‐analysis;British Journal of Clinical Pharmacology;2021-05-16
2. Genotype‐guided warfarin therapy: Still of only questionable value two decades on;Journal of Clinical Pharmacy and Therapeutics;2020-03-13
3. Meta-Analysis of Genotype-Guided Versus Standard Dosing of Vitamin K Antagonists;The American Journal of Cardiology;2018-04
4. Statistical approaches for evaluating surrogate outcomes in clinical trials: A systematic review;Journal of Biopharmaceutical Statistics;2016-02-26
5. Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service – results from the prospective, multi-center, observational cohort study thrombEVAL;BMC Medicine;2015-01-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3